Cohen Klingenstein’s Moderna MRNA Stock Holding History

Cohen Klingenstein’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$404K	Buy	+2,100	New	+$226K	0.01%	190
2024 Q3	–	Sell	-2,100	Closed	-$249K	–	222
2024 Q2	$249K	Hold	2,100	–	–	0.01%	219
2024 Q1	$224K	Hold	2,100	–	–	0.01%	220
2023 Q4	$209K	Hold	2,100	–	–	0.01%	219
2023 Q3	$217K	Hold	2,100	–	–	0.01%	219
2023 Q2	$255K	Hold	2,100	–	–	0.01%	215
2023 Q1	$323K	Hold	2,100	–	–	0.02%	207
2022 Q4	$377K	Hold	2,100	–	–	0.02%	200
2022 Q3	$248K	Hold	2,100	–	–	0.01%	216
2022 Q2	$300K	Hold	2,100	–	–	0.02%	212
2022 Q1	$362K	Hold	2,100	–	–	0.02%	211
2021 Q4	$533K	Sell	2,100 -25	-1%	-$7.31K	0.02%	192
2021 Q3	$818K	Buy	+2,125	New	+$784K	0.04%	193

Other funds holding MRNA

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Cohen Klingenstein's MRNA Position: Q3 2026 in Review

Cohen Klingenstein opened a new position in Moderna (MRNA) in Q3 2026: 2,100 shares worth $404K. The stake represents 0.01% of the portfolio and ranks #190 among its holdings. This is a return to the name: Cohen Klingenstein previously reported a position in MRNA as recently as Q2 2024.

Cohen Klingenstein first reported a position in MRNA in Q3 2021 and has held it in 13 quarters since. The position peaked at $818K in Q3 2021. 332 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Cohen Klingenstein held 2,100 shares of Moderna worth $404K as of Q3 2026.
Moderna was a new Cohen Klingenstein position in Q3 2026.
Moderna made up 0.01% of Cohen Klingenstein's portfolio in Q3 2026, its #190 holding.
Cohen Klingenstein first reported a position in Moderna in Q3 2021 and has held it in 13 quarters since.
Cohen Klingenstein's Moderna position peaked at $818K in Q3 2021.
332 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.